Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 4/20 | 0.54 |
| ▸ | DPP8 | Q6V1X1 | 4/20 | 0.54 |
| ▸ | DPP9 | Q86TI2 | 4/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.52 |
| ▸ | NOD1 | Q9Y239 | 8/20 | 0.47 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.42 |
| ▸ | MME | P08473 | 1/20 | 0.41 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31433224 | 0.91 | NOD1 (0.55) | DPP4DPP8DPP9KMT2AALOX15 | |
| SCHEMBL19375 | 0.90 | KMT2A (0.59) | DPP4DPP8DPP9KMT2AALOX15 | |
| SCHEMBL31378335 | 0.90 | KMT2A (0.59) | DPP4DPP8DPP9KMT2AALOX15 | |
| SCHEMBL5970495 | 0.90 | KMT2A (0.59) | DPP4DPP8DPP9KMT2AALOX15 | |
| SCHEMBL17941535 | 0.89 | DPP4 (0.55) | DPP4DPP8DPP9NOD1DPP7 | |
| SCHEMBL8495650 | 0.89 | DPP4 (0.55) | DPP4DPP8DPP9NOD1DPP7 | |
| SCHEMBL2854257 | 0.88 | DPP8 (0.51) | DPP4DPP8DPP9NOD1DPP7 | |
| SCHEMBL8495663 | 0.88 | DPP8 (0.51) | DPP4DPP8DPP9NOD1DPP7 | |
| SCHEMBL2200199 | 0.88 | NOD1 (0.53) | DPP4DPP8DPP9KMT2AALOX15 | |
| SCHEMBL28295881 | 0.88 | NOD1 (0.53) | DPP4DPP8DPP9KMT2AALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5863937-A | PEPTIDE CONJUGATED COMPOUND AS FUNGICIDES, BACTERICIDES, MICROBIOCIDES TREATING CANDIDA ALBICANS INFECTION | BTG INTERNATIONAL LIMITED (GB) | 1999-01-26 | — | — | US | claimed |
| EP-0722456-A1 | ANTIFUNGAL COMPOSITIONS | BTG INTERNATIONAL LIMITED (GB) | 1996-07-24 | — | — | EP | claimed |
| WO-1995009867-A1 | ANTIFUNGAL COMPOSITIONS | BRITISH TECHNOLOGY GROUP LIMITED (GB) | 1995-04-13 | — | — | WO | claimed |
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | OSMO LABS PBC (US) | 2026-03-19 | — | — | US | disclosed |
| US-20260028554-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING AROMATIC DERIVATIVES | OSMO LABS PBC (US) | 2026-01-29 | — | — | US | disclosed |
| US-20250313523-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | OSMO LABS, PBC | 2025-10-09 | — | — | US | disclosed |
| US-20250234910-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING THIENYL ALKANOATE DERIVATIVES | OSMO LABS, PBC | 2025-07-24 | — | — | US | disclosed |
| US-20250236810-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING BENZENE DERIVATIVES | OSMO LABS, PBC | 2025-07-24 | — | — | US | disclosed |
| WO-2025049824-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING AROMATIC DERIVATIVES | OSMO LABS, PBC (US) | 2025-03-06 | — | — | WO | disclosed |
| US-20250075147-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NEW FLAVOR AND FRAGRANCE INGREDIENTS | OSMO LABS, PBC | 2025-03-06 | — | — | US | disclosed |
| WO-2025049827-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING PYRAZOLE DERIVATIVES | OSMO LABS, PBC (US) | 2025-03-06 | — | — | WO | disclosed |
| EP-3247691-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NEOPENTYL GLYCOL DIACETATE | P2 Science, Inc. (US) | 2017-11-29 | — | — | EP | disclosed |
| WO-2016197000-A1 | OLFACTIVE COMPOSITIONS COMPRISING CYCLOHEXYL-ALKYL CARBINOLS | P2 SCIENCE, INC. (US) | 2016-12-08 | — | — | WO | disclosed |
| WO-2016118882-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NEOPENTYL GLYCOL DIACETATE | cP2 SCIENCE, INC. (US) | 2016-07-28 | — | — | WO | disclosed |
| US-5863937-A | PEPTIDE CONJUGATED COMPOUND AS FUNGICIDES, BACTERICIDES, MICROBIOCIDES TREATING CANDIDA ALBICANS INFECTION | BTG INTERNATIONAL LIMITED (GB) | 1999-01-26 | — | — | US | disclosed |
| US-5863937-A | PEPTIDE CONJUGATED COMPOUND AS FUNGICIDES, BACTERICIDES, MICROBIOCIDES TREATING CANDIDA ALBICANS INFECTION | BTG INTERNATIONAL LIMITED (GB) | 1999-01-26 | — | — | US | disclosed |
| EP-0722456-A1 | ANTIFUNGAL COMPOSITIONS | BTG INTERNATIONAL LIMITED (GB) | 1996-07-24 | — | — | EP | disclosed |
| EP-0722456-A1 | ANTIFUNGAL COMPOSITIONS | BTG INTERNATIONAL LIMITED (GB) | 1996-07-24 | — | — | EP | disclosed |
| WO-1995009867-A1 | ANTIFUNGAL COMPOSITIONS | BRITISH TECHNOLOGY GROUP LIMITED (GB) | 1995-04-13 | — | — | WO | disclosed |
| WO-1995009867-A1 | ANTIFUNGAL COMPOSITIONS | BRITISH TECHNOLOGY GROUP LIMITED (GB) | 1995-04-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250313523-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | CYP8B1, CYP1B1, BBOX1 | DPP4 4841/4885DPP8 3466/4885DPP9 4570/4885 |
| US-20250236810-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING BENZENE DERIVATIVES | BBOX1, NISCH, TAS2R4 | DPP4 1804/4885DPP8 2636/4885DPP9 3294/4885 |
| US-20260028554-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING AROMATIC DERIVATIVES | TAS2R42, TAS2R4, TAS2R41 | DPP4 2463/4885DPP8 3423/4885DPP9 3987/4885 |
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | CBR1, CBR3, TAS2R1 | DPP4 4882/4885DPP8 4651/4885DPP9 4873/4885 |
| US-20250234910-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING THIENYL ALKANOATE DERIVATIVES | TAS1R3, TAS2R5, TRPA1 | DPP4 2183/4885DPP8 2357/4885DPP9 1976/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.